Metformin or SGLT2 inhibitor as 1st line treatment of type 2 diabetes? Design and interim results of the SMARTEST trial J. Eriksson, L. Bennet, B. Eliasson, J. Leksell,S. Jansson, R. Kristofi,M. Lundqvist,O. Ostlund, J. SundstromDIABETES RESEARCH AND CLINICAL PRACTICE（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
